Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model-Reference-Cited by-同舟云学术

Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model

Published:1999-07 Issue:13 Volume:9 Page:1807-1812
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Miller William H.,Bondinell William E.,Cousins Russell D.,Erhard Karl F.,Jakas Dalia R.,Keenan Richard M.,Ku Thomas W.,Newlander Kenneth A.,Ross Stephen T.,Haltiwanger R.Curtis,Bradbeer Jeremy,Drake Fred H.,Gowen Maxine,Hoffman Sandra J.,Hwang Shing-Mei,James Ian E.,Lark Michael W.,Lechowska Beata,Rieman David J.,Stroup George B.,Vasko-Moser Janice A.,Zembryki Denise L.,Azzarano Leonard M.,Adams Paula C.,Salyers Kevin L.,Smith Brian R.,Ward Keith W.,Johanson Kyung O.,Huffaman William F.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference45 articles.

1. Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of theαvβ3 Integrin for a New Cancer Therapy

2. The αvβ3 integrin “vitronectin receptor”

3. The dynamic regulation of integrin adhesiveness

4. Integrin-mediated cell adhesion: the extracellular face.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ChemInform Abstract: Orally Bioavailable Nonpeptide Vitronectin Receptor Antagonists with Efficacy in an Osteoporosis Model.;ChemInform;2010-06-13

2. Role of RGD-containing ligands in targeting cellular integrins: Applications for ovarian cancer virotherapy;Experimental and Therapeutic Medicine;2010

3. Tricyclic Structures in Medicinal Chemistry: An Overview of their Recent Uses in Non-CNS Pathologies;Mini-Reviews in Medicinal Chemistry;2008-12-01

4. Palladium-Catalyzed Reductive Carbonylation of Aryl Triflates with Synthesis Gas;Synlett;2007-10

5. R-Isomers of Arg-Gly-Asp (RGD) mimics as potent αvβ3 inhibitors;Bioorganic & Medicinal Chemistry;2007-06-01